Dr Reddy's Labs targets double-digit India growth for FY25
With sales of Rs 1,330 crore in Q1 of FY25, Dr. Reddy's ranks 10th in the domestic market, according to IQVIA data.
LVMH's luxury wares earn top billing at Olympics opening
Grammy-winner Lady Gaga delivered an energetic performance of Renee 'Zizi' Jeanmaire's "Mon truc en plumes" (My Feather Friend) decked out in a Dior Haute Couture black feather jacket over a black satin bustier.
Cipla forecasts US sales run-rate at $235-$240 mn, margin to be stable at current levels
Cipla is aiming for a Q4 FY25 launch for its important respiratory drug, Advair, while awaiting the US FDA's response on corrective measures at its Goa facility, crucial for launching the chemotherapy drug Abraxane.
Tech Mahindra Q1 FY25 – great start to a turnaround year
Revenue growth, expansion in margins, and a traction in deals hold out growth hopes
In its biggest acquisition, Mankind Pharma tries to replicate its past success in M&A
Mankind Pharma is acquiring BSV at an enterprise value of Rs 13,630 crore. The last major acquisition it did was for Rs 1,872 crore.
Mankind Pharma to buy Bharat Serums from Advent for Rs 13,630 crore
Earlier on July 25, Moneycontrol had reported that Mankind Pharma had edged ahead of EQT-ADIA consortium and emerged as the front-runner for the deal
Federal Bank Q1 FY25 – change of guard amid all-round strength
A gradual improvement in the RoA should lead to a valuation rerating
Axis Bank Q1 FY25 – slower earnings trajectory ahead, warrants caution
We see a high possibility of RoA compression in the near term
How large IT companies stack up on growth rates after June quarter
TCS and LTIMindtree are projected to lead FY25 revenue growth rates. But Infosys is fast gaining momentum
Kotak Mahindra Bank Q1 FY25 – under the shadow of the embargo
The presence across the gamut of financial services augurs well for the bank in the long term
Wipro Q1 FY25: Growth remains elusive
Revenue decline and tepid guidance rule out valuation rerating for now
Infosys Q1 FY25 – Does all-round strength make the stock worthy of fresh allocation?
Deal ramp-up, BFSI demand revival, and the possible upside from large transformational deals once macro stabilises, should benefit the company
LTI Mindtree Q1 FY25 – strong quarter, encouraging outlook
Strong execution coupled with encouraging guidance on demand revival
How Tata Power’s improved balance sheet is fuelling its capex
The net debt to equity ratio declined from 3 times in FY17 to less than one in FY24
What can Union Budget 2024 deliver to excite markets further?
Budget 2024-25: Focus on capex, support to consumer sentiment, and addressing rural distress while maintaining fiscal balance are key areas to watch
Investors of TCS, HCL should tally their optimism with ISG index
ISG, which tracks commercial outsourcing contracts, lowered the growth forecast for managed services
TCS Q1 FY25 – Why the underperformance should reverse now
Return of demand with improving macro among several positive factors
KIMS should see results from Vizag hospital acquisition early
The hospital was incorporated in 2010 and generated a revenue of Rs 62 crore in FY23
Karur Vysya Bank — Is the current stock weakness an opportunity?
The bank’s earnings growth could soften going forward despite a well calibrated strategy
Bhavish Aggarwal on Ola Electric IPO launch: 'Still a bunch of steps to go through...''
Moneycontrol, on June 11, had reported that the electric vehicle maker had received Sebi's clearance for its IPO. The company is looking to raise Rs 7,250 crore through the IPO
Capital Small Finance Bank – Why the time is right to look at this stock
Unlike most SFBs, Capital’s loan book is largely secured and the liability profile is granular
Tata Chemicals’ fortunes tied to soda ash amid slow ramp-up of specialty business
Rising global supplies are feared to weigh on soda ash prices and realisations in 2024
Hyundai Motor India Foundation announces CSR prog for Maharashtra
The programmes launched in the health and sanitation sectors, among others, include unveiling of five telemedicine clinics along with two mobile medical vans that were flagged off under a particular project, a statement said
Why the Q1 business updates from banks are not music to investors’ ears
Deposit growth not keeping pace with loan growth, keeping the CD ratio elevated
JSW-MG Motor readies five new cars, to focus more on EVs, hybrid vehicles
Analysts believe that with its latest portfolio priced up to Rs 35 lakhs, MG is well-positioned to compete directly with its rivals, as plug-in hybrids are seen as a practical choice due to current limitations in charging infrastructure
